Studied individuals undergoing genetic testing for a familial BRCA1/2 mutation or mutation predisposing to HNPCC. There were no differences between BRCA1/2 and HNPCC families in levels of perceived risk. For both groups, actual carriers reported greater perceived risk after disclosure of a positive test result. The gene discussed is BRCA1; the disease is hereditary nonpolyposis colon cancer.